Clinical Trial

Safety and Efficacy of Mitapivat Sulfate in Adult Patients With Erythrocyte Membranopathies

Study acronym: SATISFY
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated December 26, 2023 (before its estimated July 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective exploratory multicentre pilot study designed to study the safety and efficacy of mitapivat in RBC membranopathies and CDAII
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-06-29; most recent amendment 2023-12-19.
Trial Details
NCT Number NCT05935202
Lead Sponsor EuroBloodNet Association
Conditions Hereditary Red Blood Cell Disorder (Disorder)
Enrollment 25 participants
Start Date 2023-12-21
Primary Completion 2025-07-15 (estimated)
Study Completion 2026-12-15 (estimated)
Updated on ClinicalTrials.gov 2023-12-26